                         SEQUENCE LISTING

<110>  Universit de Strasbourg et al
 
<120>  AUTOPHAGY-INDUCING MOLECULES FOR INCREASING INSULIN RELEASE

<130>  B1961PC

<160>  14    

<170>  PatentIn version 3.5

<210>  1
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  1

Val Phe Asn Ala Thr Phe His Ile Trp His Ser Gly Gln Phe 
1               5                   10                  


<210>  2
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  2

Thr Asn Val Phe Asn Ala Thr Phe His Ile Trp His Ser Gly Gln Phe 
1               5                   10                  15      


Gly Thr 
        


<210>  3
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is His or Glu

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Asp or Ser

<400>  3

Val Phe Asn Ala Thr Phe Xaa Ile Trp His Xaa 
1               5                   10      


<210>  4
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is His or Glu

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is Asp or Ser

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Gln or Glu

<400>  4

Thr Asn Val Phe Asn Ala Thr Phe Xaa Ile Trp His Xaa Gly Xaa Phe 
1               5                   10                  15      


Gly Thr 
        


<210>  5
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  5

Val Phe Asn Ala Thr Phe Glu Ile Trp His Asp 
1               5                   10      


<210>  6
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  6

Thr Asn Val Phe Asn Ala Thr Phe Glu Ile Trp His Asp Gly Glu Phe 
1               5                   10                  15      


Gly Thr 
        


<210>  7
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  7

Thr Gly Phe Glu Gly Asp His Trp Ile Glu Phe Thr Ala Asn Phe Val 
1               5                   10                  15      


Asn Thr 
        


<210>  8
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  8

Arg Arg Arg Arg Arg Arg Arg Arg 
1               5               


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  9

Arg Arg Pro Arg Arg Pro Arg Arg Pro Arg Arg Pro Arg Arg Pro 
1               5                   10                  15  


<210>  10
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  10

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  11
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  11

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  12
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  12

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Gly Thr Asn Val 
1               5                   10                  15      


Phe Asn Ala Thr Phe His Ile Trp His Ser Gly Gln Phe Gly Thr 
            20                  25                  30      


<210>  13
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  13

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Gly Thr Asn Val 
1               5                   10                  15      


Phe Asn Ala Thr Phe Glu Ile Trp His Asp Gly Glu Phe Gly Thr 
            20                  25                  30      


<210>  14
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  14

Arg Arg Arg Gln Arg Arg Lys Lys Arg Gly Tyr Gly Gly Thr Gly Phe 
1               5                   10                  15      


Glu Gly Asp His Trp Ile Glu Phe Thr Ala Asn Phe Val Asn Thr 
            20                  25                  30      


